203 related articles for article (PubMed ID: 26381288)
1. The role of steroid hormones in breast cancer stem cells.
Simões BM; Alferez DG; Howell SJ; Clarke RB
Endocr Relat Cancer; 2015 Dec; 22(6):T177-86. PubMed ID: 26381288
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
Kabos P; Finlay-Schultz J; Li C; Kline E; Finlayson C; Wisell J; Manuel CA; Edgerton SM; Harrell JC; Elias A; Sartorius CA
Breast Cancer Res Treat; 2012 Sep; 135(2):415-32. PubMed ID: 22821401
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptors and their role in the biology and control of breast cancer growth.
Cordera F; Jordan VC
Semin Oncol; 2006 Dec; 33(6):631-41. PubMed ID: 17145341
[TBL] [Abstract][Full Text] [Related]
4. The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes.
Sreekumar A; Roarty K; Rosen JM
Endocr Relat Cancer; 2015 Dec; 22(6):T161-76. PubMed ID: 26206777
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer.
Elangovan S; Ramachandran S; Venkatesan N; Ananth S; Gnana-Prakasam JP; Martin PM; Browning DD; Schoenlein PV; Prasad PD; Ganapathy V; Thangaraju M
Cancer Res; 2011 Nov; 71(21):6654-64. PubMed ID: 21920899
[TBL] [Abstract][Full Text] [Related]
6. Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines.
Fan P; McDaniel RE; Kim HR; Clagett D; Haddad B; Jordan VC
Eur J Cancer; 2012 Dec; 48(18):3488-98. PubMed ID: 22658320
[TBL] [Abstract][Full Text] [Related]
7. MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.
Lee JY; Won HY; Park JH; Kim HY; Choi HJ; Shin DH; Kang JH; Woo JK; Oh SH; Son T; Choi JW; Kim S; Kim HY; Yi K; Jang KS; Oh YH; Kong G
J Clin Invest; 2015 May; 125(5):1801-14. PubMed ID: 25822021
[TBL] [Abstract][Full Text] [Related]
8. Mammary gland growth and development from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse.
Fendrick JL; Raafat AM; Haslam SZ
J Mammary Gland Biol Neoplasia; 1998 Jan; 3(1):7-22. PubMed ID: 10819501
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormones, steroid receptors, and breast cancer stem cells.
Finlay-Schultz J; Sartorius CA
J Mammary Gland Biol Neoplasia; 2015 Jun; 20(1-2):39-50. PubMed ID: 26265122
[TBL] [Abstract][Full Text] [Related]
10. The regulation of estrogen receptor expression and function in human breast cancer.
Ferguson AT; Lapidus RG; Davidson NE
Cancer Treat Res; 1998; 94():255-78. PubMed ID: 9587692
[No Abstract] [Full Text] [Related]
11. Mechanisms of action of endocrine treatment in breast cancer.
Lønning E; Lien EA
Crit Rev Oncol Hematol; 1995 Nov; 21(1-3):158-93. PubMed ID: 8822501
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Stem Cells and Sex Steroid Hormones.
Flores-Ramírez I; Baranda-Avila N; Langley E
Curr Stem Cell Res Ther; 2019; 14(5):398-404. PubMed ID: 30095060
[TBL] [Abstract][Full Text] [Related]
13. Biological roles of estrogen and progesterone in human endometrial carcinoma--new developments in potential endocrine therapy for endometrial cancer.
Ito K; Utsunomiya H; Yaegashi N; Sasano H
Endocr J; 2007 Dec; 54(5):667-79. PubMed ID: 17785917
[TBL] [Abstract][Full Text] [Related]
14. Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.
He Q; Liang CH; Lippard SJ
Proc Natl Acad Sci U S A; 2000 May; 97(11):5768-72. PubMed ID: 10811891
[TBL] [Abstract][Full Text] [Related]
15. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
[TBL] [Abstract][Full Text] [Related]
16. Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer.
Walter V; Fischer C; Deutsch TM; Ersing C; Nees J; Schütz F; Fremd C; Grischke EM; Sinn P; Brucker SY; Schneeweiss A; Hartkopf AD; Wallwiener M
Breast Cancer Res Treat; 2020 Aug; 183(1):137-144. PubMed ID: 32613540
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
18. Progestins and antiprogestins in mammary tumour growth and metastasis.
Shi YE; Liu YE; Lippman ME; Dickson RB
Hum Reprod; 1994 Jun; 9 Suppl 1():162-73. PubMed ID: 7962461
[TBL] [Abstract][Full Text] [Related]
19. A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
Fox EM; Miller TW; Balko JM; Kuba MG; Sánchez V; Smith RA; Liu S; González-Angulo AM; Mills GB; Ye F; Shyr Y; Manning HC; Buck E; Arteaga CL
Cancer Res; 2011 Nov; 71(21):6773-84. PubMed ID: 21908557
[TBL] [Abstract][Full Text] [Related]
20. Estrogen signaling pathway and hormonal therapy.
Hayashi S; Yamaguchi Y
Breast Cancer; 2008; 15(4):256-61. PubMed ID: 18818989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
